Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459270) titled 'Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Use' on March 4.

Study Type: Observational

Primary Sponsor: Elazig Mental Health and Diseases Hospital

Condition: Methamphetamine Induced Psychosis Cannabis Use

Recruitment Status: Not recruiting

Date of First Enrollment: March 16, 2026

Target Sample Size: 90

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07459270

Published by HT Digital Content Services with permission from Health Daily Digest....